CURRENTLY SOLD OUT
Best-selling in Textbooks
Save on Textbooks
- AU $56.99Trending at AU $71.18
- AU $13.90Trending at AU $17.77
- AU $29.08Trending at AU $33.18
- AU $30.74Trending at AU $37.24
- AU $23.06Trending at AU $32.85
- AU $71.09Trending at AU $79.99
- AU $50.05Trending at AU $66.59
About this product
- DescriptionThe FMR1 gene is an example of how a single gene can have different phetypic effects. Indeed, since its discovery in 1991 it has revealed new facets: classic Fragile X syndrome (FXS), Fragile X premature ovarian insufficiency (FXPOI), Fragile X tremor-ataxia syndrome (FXTAS) and other emerging disorders from which we are continuously learning more about this gene. The chapters of this book provide an update of the different allelic forms of the FMR1 gene. Chapter 1 is a description of the classical Fragile X syndrome including clinical findings in males and females, the FMR1 gene, molecular bases, the FMRP protein, animal models, genetic counselling, new-born screening and diagsis. Chapters 2 and 3 review the two main disorders associated with FMR1 premutation: FXPOI and FXTAS. FXPOI is a new clinical entity in which carrier premutation (PM) females present early ovarian dysfunction, with mepause occurring 5 years earlier than n-carrier family members. FXTAS is a late-onset inherited neuropsychiatric degenerative disorder that occurs predominantly in male carriers of the FMR1 premutation. Chapters 4 and 5 present the most recent advances in the current kwledge of other disorders associated with the FMR1 gene: Chapter 4 describes the psychopathological alterations of the different phetypes associated with either premutation or full mutation. Chapter 5 is focused on the pathologies associated with the premutation such as fibromyalgia, thyroid disease and hypertension, among others. A comprehensive review of genetic counselling is done in Chapter 6 including all types of alleles related to the FMR1 gene and point mutations. Finally, although at present there is treatment for any of these pathologies, an update of the clinical trials on therapies for all these FMR1 gene-related disorders and their current status is made in Chapter 7.
- PublisherNova Science Publishers Inc
- Date of Publication01/04/2015
- SubjectMedicine: General
- Place of PublicationNew York
- Country of PublicationUnited States
- ImprintNova Science Publishers Inc
- Weight368 g
- Width155 mm
- Height230 mm
- Edited byMontserrat Mila
This item doesn't belong on this page.
Thanks, we'll look into this.